Anti-NMDA receptor encephalitis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Absolutely healthy children of any age can spontaneously develop antibodies which bind to certain brain structures, the so-called N-methyl-D-aspartate (NMDA) receptors. The binding of these antibodies blocks the receptors and causes slowly progressive mental disorders, motor abnormalities, and seizures. The paper describes a clinical case of a disease in a 9-year-old female patient. The disease onset is marked by the manifestation of prodromal flu-like symptoms, fever, headache, and general weakness, followed by neuropsychiatric symptoms and impairments in memory and speech. Further progression of the disease caused convulsive status and later coma. The final diagnosis of autoimmune encephalitis was established after the complete blood count test identified anti-NMDA receptor antibodies.

Full Text

Restricted Access

About the authors

Lala U. Ulukhanova

Dagestan State Medical University, Ministry of Health of Russia

Email: lala.uluhanova@mail.ru
MD, Head, Department of Propaedeutics of Children’s Diseases with a Course of Children’s Infections Makhachkala, Russia

Magomedzagir M. Yaraliev

S.M. Magomedov Dagestan Republican Center for Infectious Diseases, Prevention and Control of AIDS

Email: zagir0668@mail.ru
Head, Resuscitation Department Makhachkala, Russia

Nargiz S. Karnaeva

Dagestan State Medical University, Ministry of Health of Russia

Email: karnaeva79@mail.ru
Cand. Med. Sci., Assistant Lecturer, Department of Propaedeutics of Childhood Diseases with Course of Childhood Infections Makhachkala, Russia

References

  1. Chapman M.R., Vause H.E. Anti-NMDA Receptor encephalitis: diagnosis, psychiatric presentation, and treatment. J. Psychiat 2011; 168(3): 245-51. Am. J. Psychiatr. 2011; 168(3): 245-51. DOI: 10.1176/ ppi. ajp.2010.10020181.
  2. Florance N.R. Anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Ann. Neurol. 2010; http://www.ncbi.nlm.nih. gov/pmc/articles/PMC2826225
  3. Iizuka T., Sakai F., Ide T., Monzen T., Yoshii S., Iigaya M., Suzuki K., Lynch D.R., Suzuki N., Hata T., Dalmau J. (February 2008). Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008; 70 (7): 504-11. doi: 10.1212/01.wnl. 0000278388.90370. c3. PMID: 17898324.
  4. Dalmau J., Tüzün E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Mason W., Sansing L.H., Dichter M.A., Rosenfeld M.R., Lynch D.R. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 2007; 61 (1): 25-36. doi: 10.1002/ana.21050. PMID: 17262855.
  5. Florance N.R., Davis R.L., Lam C., Szperka C., Zhou L., Ahmad S., Campen C.J., Moss H., Peter N., Gleichman A.J., Glaser C.A., Lynch D.R., Rosenfeld M.R., Dalmau J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol. 2009; 66(1): 11-8. doi: 10.1002/ana.21756. PMID: 19670433.
  6. Sansing L.H., Tüzün E., Ko M.W., Baccon J., Lynch D.R., Dalmau J. (May 2007). A patient with encephalitis associated with NMDA receptor antibodies. Nat. Clin. Pract. Neurol. 2007; 3(5): 291-6. DOI:10.1038/ ncpneuro0493. PMID: 17479076.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media